| Tania Kraai, MD | |
|
Unm Hospital Otolaryngology, 2211 Lomas Blvd Ne, Albuquerque, NM 87131-0001 | |
| (505) 272-6225 | |
| Not Available |
| Full Name | Tania Kraai |
|---|---|
| Gender | Female |
| Speciality | Otolaryngology |
| Experience | 21 Years |
| Location | Unm Hospital Otolaryngology, Albuquerque, New Mexico |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1295874238 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Y00000X | Otolaryngology | 2003R287 (New Mexico) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| University Of New Mexico Hospital | Albuquerque, NM | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| University Of New Mexico Medical Group | 4981795267 | 1002 |
News Archive
Cardiac experts at Rush University Medical Center are studying a new, minimally invasive procedure to treat leaky heart valves. Instead of open heart surgery, patients will undergo a less complex catheter-based procedure to treat mitral regurgitation, a serious heart disorder where blood leaks backwards toward the lungs with each heart beat.
A new Harvard Medical School analysis shows that papers that present research on health conditions within sub-Saharan African countries in collaboration with wealthy or prestigious institutions or countries often fail to mention local researchers working on the same project, especially in prime positions such as first or senior author. The paper was published on October 18, 2019, in the journal BMJ Global Health.
Viventia Biotech has announced results of in vitro cytotoxicity and in vivo pharmacokinetic studies conducted to evaluate the potential for combining its phase III anti-cancer antibody therapeutic, Proxinium, with first-line standard of care therapy for squamous cell carcinoma of the head & neck (SCCHN).
AMHN, Inc. (the "Company"), parent company of America's Minority Health Network, Inc. ("America's Minority Health Network"), announced today its plan to expand network operations and relocate its offices to Burbank.
A large, multi-center heart disease prevention study, part of the Women's Health Initiative (WHI), found that estrogen-alone hormone therapy had no effect on coronary heart disease risk but increased the risk of stroke for postmenopausal women.
› Verified 8 days ago
| Entity Name | Unm Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1831218627 PECOS PAC ID: 4981795267 Enrollment ID: O20070801000589 |
News Archive
Cardiac experts at Rush University Medical Center are studying a new, minimally invasive procedure to treat leaky heart valves. Instead of open heart surgery, patients will undergo a less complex catheter-based procedure to treat mitral regurgitation, a serious heart disorder where blood leaks backwards toward the lungs with each heart beat.
A new Harvard Medical School analysis shows that papers that present research on health conditions within sub-Saharan African countries in collaboration with wealthy or prestigious institutions or countries often fail to mention local researchers working on the same project, especially in prime positions such as first or senior author. The paper was published on October 18, 2019, in the journal BMJ Global Health.
Viventia Biotech has announced results of in vitro cytotoxicity and in vivo pharmacokinetic studies conducted to evaluate the potential for combining its phase III anti-cancer antibody therapeutic, Proxinium, with first-line standard of care therapy for squamous cell carcinoma of the head & neck (SCCHN).
AMHN, Inc. (the "Company"), parent company of America's Minority Health Network, Inc. ("America's Minority Health Network"), announced today its plan to expand network operations and relocate its offices to Burbank.
A large, multi-center heart disease prevention study, part of the Women's Health Initiative (WHI), found that estrogen-alone hormone therapy had no effect on coronary heart disease risk but increased the risk of stroke for postmenopausal women.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Tania Kraai, MD 2211 Lomas Blvd Ne, Msc 084770, Albuquerque, NM 87131-0001 Ph: (505) 272-6225 | Tania Kraai, MD Unm Hospital Otolaryngology, 2211 Lomas Blvd Ne, Albuquerque, NM 87131-0001 Ph: (505) 272-6225 |
News Archive
Cardiac experts at Rush University Medical Center are studying a new, minimally invasive procedure to treat leaky heart valves. Instead of open heart surgery, patients will undergo a less complex catheter-based procedure to treat mitral regurgitation, a serious heart disorder where blood leaks backwards toward the lungs with each heart beat.
A new Harvard Medical School analysis shows that papers that present research on health conditions within sub-Saharan African countries in collaboration with wealthy or prestigious institutions or countries often fail to mention local researchers working on the same project, especially in prime positions such as first or senior author. The paper was published on October 18, 2019, in the journal BMJ Global Health.
Viventia Biotech has announced results of in vitro cytotoxicity and in vivo pharmacokinetic studies conducted to evaluate the potential for combining its phase III anti-cancer antibody therapeutic, Proxinium, with first-line standard of care therapy for squamous cell carcinoma of the head & neck (SCCHN).
AMHN, Inc. (the "Company"), parent company of America's Minority Health Network, Inc. ("America's Minority Health Network"), announced today its plan to expand network operations and relocate its offices to Burbank.
A large, multi-center heart disease prevention study, part of the Women's Health Initiative (WHI), found that estrogen-alone hormone therapy had no effect on coronary heart disease risk but increased the risk of stroke for postmenopausal women.
› Verified 8 days ago
Dr. Alan Steven Brenner, M.D. Otolaryngology Medicare: Medicare Enrolled Practice Location: 201 Cedar St Se, Suite 4600, Albuquerque, NM 87106 Phone: 505-563-6450 Fax: 505-563-6484 | |
Dr. Miriam I Redleaf, M.D. Otolaryngology Medicare: May Accept Medicare Assignments Practice Location: University Of New Mexico, 2211 Lomas Blvd Ne, Albuquerque, NM 87106 Phone: 505-272-6487 | |
Roland Zsolt Gerencer, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 4901 Lang Ave Ne, Albuquerque, NM 87109 Phone: 505-842-8171 Fax: 505-246-0684 | |
Dr. Donald Z. Sokol, M.D. Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 1501 San Pedro Dr Se, Albuquerque, NM 87108 Phone: 505-265-1711 | |
George David Neal, MD Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 5400 Gibson Blvd Se, Albuquerque, NM 87108 Phone: 505-262-7905 Fax: 505-262-3484 | |
Angela Martin, MD Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 2nd Ambulatory Care Ctr, 2211 Lomas Blvd. Ne, Albuquerque, NM 87131 Phone: 505-272-6452 |